BissonnetteR.NigenS.LangleyRGet al. Increased expression of IL-17A and limited involvement of IL-23 in patients with palmo-plantar (PP) pustular psoriasis or PP pustulosis; results from a randomised controlled trial. J Eur Acad Dermatol Venereol. 2014;28(10):1298-1305.doi:10.1111/jdv.1227224112799
2.
GhiasMH.HydeMJ.TomalinLEet al. Role of the complement pathway in inflammatory skin diseases: a focus on hidradenitis suppurativa. J Invest Dermatol. 2020;140(3):531-536.doi:10.1016/j.jid.2019.09.00931870626
3.
WangJ.Suárez-FariñasM.EstradaYet al. Identification of unique proteomic signatures in allergic and non-allergic skin disease. Clin Exp Allergy. 2017;47(11):1456-1467.doi:10.1111/cea.1297928703865
4.
KanniT.ZenkerO.HabelM.RiedemannN.Giamarellos-BourboulisEJ. Complement activation in hidradenitis suppurativa: a new pathway of pathogenesis?Br J Dermatol. 2018;179(2):413-419.doi:10.1111/bjd.1642829405257
5.
LaudisiF.SpreaficoR.EvrardMet al. Cutting edge: the NLRP3 inflammasome links complement-mediated inflammation and IL-1β release. J Immunol. 2013;191(3):1006-1010.doi:10.4049/jimmunol.130048923817414
